Clinical Trial Update: Sleep Disorders and Gastroesophageal Reflux Disease (GERD) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update from University of North Carolina investigating insomnia and gastroesophageal reflux disease; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease
• Insomnia

Snippet

Sponsor: University of North Carolina | Conditions: Insomnia, GERD | Phase 4 | Status: COMPLETED